🧭 What is regulated under BPR?

🧪 Biocidal products (and product families)

Biocidal products generally must be authorised under BPR before they are made available on the market or used (with defined authorisation routes).

🧵 Treated articles

Articles treated with, or intentionally incorporating, biocidal products (e.g., treated textiles, plastics, coatings) have specific BPR obligations—especially around allowed active substances and labelling triggers.

🧩 Product Types (PTs)

BPR divides uses into 22 Product Types (PT1–PT22). Correct PT assignment drives the correct approval/authorisation pathway and data requirements.

✅ What a company must do to comply (practical roadmap)

1) 🗺️ Scope your portfolio and classify correctly (PT + use + claims)

Do this first, before dossiers and labels:

• Map each SKU to: PT, target organisms, surfaces/materials, intended users (general public vs professional), and claims (incl. “kills X%”, “long-lasting”, “antimicrobial”).
• Decide whether you are dealing with:
• a biocidal product,
• a biocidal product family (variants under one authorisation),
• or a treated article claim scenario.

Compliance output: a controlled “regulatory identity” sheet per SKU (PT, uses, claims, markets, legal entity).

2) 🧬 Verify active substance status and “source” (approval + technical equivalence)

For every formulation and PT:

• Confirm the active substance is supported for the relevant PT under BPR (or within applicable transitional/review provisions where relevant).
• Confirm your active substance source aligns with what is supported/assessed; if the source changes, you may need technical equivalence assessment.

Compliance output: active substance/PT matrix + supplier/source evidence pack.

3) 🧾 Implement Article 95 supply-chain gating (don’t buy the wrong source)

BPR’s Article 95 framework requires (in many cases) that the relevant active substance supplier or product supplier is appropriately listed/covered—this is a frequent enforcement and market-access failure point if unmanaged.

What to do operationally

• Tie procurement approval to: active substance, PT, supplier/site, and listing/evidence.
• Re-check Article 95 coverage when suppliers, sites, or formulations change.

Compliance output: “no Article 95 evidence → no purchase / no release” control.

4) 🧭 Choose the right authorisation route (and build your plan)

BPR authorisation pathways commonly include:

• National authorisation (one Member State) + mutual recognition to expand to others.
• Union authorisation (single authorisation for eligible products across the Union).
• Simplified authorisation for qualifying lower-concern products (where conditions apply).
• Biocidal product family approach to manage variants under one authorisation.

Compliance output: authorisation strategy (markets, route, timeline drivers, dossier ownership, data plan).

5) 📩 Prepare submissions properly (R4BP 3 + IUCLID discipline)

All key submissions are handled through R4BP 3 (Register for Biocidal Products)—the central hub for submitting and following up applications to ECHA and national authorities.

What good looks like

• Structured dossier data (consistent identity/composition, claims, uses, evidence mapping).
• Controlled document sets: study lists, justification documents, confidentiality claims, correspondence log.
• Internal review gates before submission (regulatory + technical + label/claims alignment).

Compliance output: inspection-ready dossier library and version control.

6) 🏷️ Control labelling and advertising (high takedown / enforcement risk)

Advertising (Article 72)

Any advertisement must include the required safety sentences (with limited permitted wording substitutions) and must be clearly legible.

Labels and “what you claim”

• Ensure label text and marketing claims do not drift from the authorised conditions (e.g., organisms, contact time, concentrations, surfaces, user groups).
• Build a “claims library” tied to evidence and authorised uses.

Compliance output: label + marketing approval workflow with traceable approvals.

7) 🧵 Treated articles: manage labelling triggers and substance constraints

If you sell treated materials/articles and make biocidal claims (or if approval conditions require it), you must meet treated-article obligations and labelling requirements.

Operational controls

• Treated-article SKU register (materials, suppliers, active substances, intended properties).
• Labelling trigger rules (claim-based and approval-condition-based).
• Supplier declarations and evidence retention.

Compliance output: treated-article governance pack (SKU matrix + label trigger logic + supplier evidence).

8) 🔁 Post-authorisation compliance: keep it valid and audit-ready

BPR compliance is continuous:

• Manage renewals/updates through controlled calendars and change control.
• Treat changes (composition, supplier/site, label/claims, new risk information) as regulated events requiring structured assessment and documentation.

Compliance output: change-control SOPs + renewal calendar + evidence trail.

🧰 What this BPR compliance service delivers

📌 Portfolio scoping & route selection

• PT classification, biocide vs treated-article determination
• Active substance/PT screening + source checks
• Route recommendation: national/MR/Union/simplified/family

📚 Dossier readiness & submission support

• Submission-ready dossier structure aligned to R4BP 3 processes
• Evidence/claims mapping and controlled documentation

🏷️ Label & advertising governance

• Article 72-compliant ad checks and reusable templates
• Label/claims workflows to avoid drift and enforcement issues

🧵 Treated-articles compliance program

• Treated-article inventory, labelling triggers, supplier evidence model

🔁 Ongoing compliance operations

• Article 95 supply chain gating + technical equivalence change triggers
• Renewal calendar + inspection-ready recordkeeping

⭐ Why ComplyMarket for Biocidal Products Regulation compliance

ComplyMarket is a powerful material compliance management and reporting platform built to make BPR compliance structured, provable, and scalable across products, markets, and suppliers.

With ComplyMarket you can:

• Centralize product composition, variants, PT mappings, and approved claims with version control
• Enforce Article 95 supplier validation as a procurement/release gate
• Maintain dossier-ready structured data and submission document sets
• Run label/claims approvals with full audit trails (including Article 72 advertising checks)
• Track treated-article obligations across components and finished goods
• Operate renewals, change control, and inspection readiness in one integrated workflow

If you want BPR compliance without chaos—and with evidence always ready—ComplyMarket is the best-ever solution to operationalize Biocidal Products Regulation requirements end-to-end.